FDA wants another panel hearing on Boston Scientific's Watchman anti-stroke device

The FDA wants to convene another advisory panel on Boston Scientific's Watchman anti-stroke heart repair device, CFO Dan Brennan told investors today in Boston, saying the development pushes the approval timeline into 2015.

Boston Scientific, Food & Drug Administration (FDA)

News Well, Cardiac Implants, Regulatory/Compliance, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oBhIJp